GE Healthcare files patent lawsuit against Bio-Rad
05-12-2018
General Electric (GE) has bought three life sciences divisions from US company Thermo Fisher Scientific in a deal worth about $1.06 billion.
You need a subscription to continue reading this content.
Start a subscription today to access the LSIPR website.
To access the full archive, digital magazines and special reports you will need to take out a paid subscription.
If you have already subscribed please login.
If you have any technical issues please email tech support.
For access to the complete website, archive, and to receive print publications, choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial with full access, select ‘TWO WEEK FREE TRIAL’.
general electric, thermo fisher scientific, GE healthcare, cell culture, gene modulation, magnetic beads
